NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions

Effect of NKG2D ligand expression on host immune responses

(2015) Marine Champsaur et al.   IMMUNOLOGICAL REVIEWS

Natural Killer Cell Responses to Viral Infection

(2011) Joshua D. Brandstadter et al.   Journal of Innate Immunity

The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells

(2011) Rebekka Wehner et al.   Journal of Innate Immunity

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

(2010) Federico Garrido et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interleukin 10 decreases MICA expression on melanoma cell surface

(2010) Antonio E Serrano et al.   IMMUNOLOGY AND CELL BIOLOGY

Immunity unleashed in melanoma

(2010) Michael K Erdmann   LANCET ONCOLOGY

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

(2010) M Carlsten et al.   LEUKEMIA

New views on natural killer cell-based immunotherapy for melanoma treatment

(2010) Shannon Burke et al.   TRENDS IN IMMUNOLOGY

Natural Killer Cells: Tolerance to Self and Innate Immunity to Viral Infection and Malignancy

(2009) Wayne M. Yokoyama et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

(2009) Gordana Konjević et al.   BIOMARKERS

HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank

(2009) Rosa Mendez et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

(2009) Miroslaw J. Szczepanski et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

(2009) Javier G. Casado et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B

(2009) A. Paschen et al.   CLINICAL CANCER RESEARCH

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

(2009) Tadepally Lakshmikanth et al.   JOURNAL OF CLINICAL INVESTIGATION

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

(2009) M. Carlsten et al.   JOURNAL OF IMMUNOLOGY

DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

(2009) C. J. Chan et al.   JOURNAL OF IMMUNOLOGY

Natural Cytotoxicity Receptors NKp30, NKp44 and NKp46 Bind to Different Heparan Sulfate/Heparin Sequences

(2009) Marie-Lyn Hecht et al.   JOURNAL OF PROTEOME RESEARCH

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells

(2009) Gal Markel et al.   PLoS One

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells

(2009) Paolo Carrega et al.   PLoS One

Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells

(2009) L. J. Berry et al.   TISSUE ANTIGENS

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

(2008) Karl-Johan Malmberg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Line of attack: NK cell specificity and integration of signals

(2008) Yenan T Bryceson et al.   CURRENT OPINION IN IMMUNOLOGY

Negative signaling by inhibitory receptors: the NK cell paradigm

(2008) Eric O. Long   IMMUNOLOGICAL REVIEWS

Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

(2008) Nicole Schwinn et al.   INTERNATIONAL JOURNAL OF CANCER

Accelerated tumor growth in mice deficient in DNAM-1 receptor

(2008) Akiko Iguchi-Manaka et al.   JOURNAL OF EXPERIMENTAL MEDICINE

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

(2008) Susan Gilfillan et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Natural killer cell–directed therapies: moving from unexpected results to successful strategies

(2008) Magali Terme et al.   NATURE IMMUNOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

Expression of Ligands to NKp46 in Benign and Malignant Melanocytes

(2007) Emanuela Cagnano et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY